Such models should be able to simulate how the RA treatment downregulates the expression of TF and CP and upregulates the synthesis of PAI-1, PAI-2, t-PA and u-PA in various cell types such as endothelial cells, monocytes, and tumor cells. The gene discussed is CP; the disease is neoplasm.